Loading…
Lobbying Income
$790K
Filings
54
Unique Clients
2
Active Period
2012–2019
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Elijah E. Cummings Lower Drug Costs Now Act
2019 · fourth_quarter · Client: LILLY USA, LLC
Opposition to prescription drug importation and cuts to Medicare Part D funding. Support for funding of Department of Homeland Security drug interdiction efforts. Issues related to pricing of prescription drugs. Monitoring H.R.3, Lower Drug Costs Now Act of 2019 and S.2543, Prescription Drug Pricing Reduction Act of 2019.
Client expense: — · Firm income: $20,000
Matched citations: H.R.3
Prescription Drug Pricing Reduction Act of 2019
2019 · fourth_quarter · Client: LILLY USA, LLC
Opposition to prescription drug importation and cuts to Medicare Part D funding. Support for funding of Department of Homeland Security drug interdiction efforts. Issues related to pricing of prescription drugs. Monitoring H.R.3, Lower Drug Costs Now Act of 2019 and S.2543, Prescription Drug Pricing Reduction Act of 2019.
Client expense: — · Firm income: $20,000
Matched citations: S.2543
Elijah E. Cummings Lower Drug Costs Now Act
2019 · fourth_quarter · Client: LILLY USA, LLC
Opposition to prescription drug importation and cuts to Medicare Part D funding. Support for funding of Department of Homeland Security drug interdiction efforts. Issues related to pricing of prescription drugs. Monitoring H.R.3, Lower Drug Costs Now Act of 2019 and S.2543, Prescription Drug Pricing Reduction Act of 2019.
Client expense: — · Firm income: $20,000
Matched citations: H.R.3
Prescription Drug Pricing Reduction Act of 2019
2019 · fourth_quarter · Client: LILLY USA, LLC
Opposition to prescription drug importation and cuts to Medicare Part D funding. Support for funding of Department of Homeland Security drug interdiction efforts. Issues related to pricing of prescription drugs. Monitoring H.R.3, Lower Drug Costs Now Act of 2019 and S.2543, Prescription Drug Pricing Reduction Act of 2019.
Client expense: — · Firm income: $20,000
Matched citations: S.2543
Elijah E. Cummings Lower Drug Costs Now Act
2019 · third_quarter · Client: LILLY USA, LLC
Opposition to prescription drug importation and cuts to Medicare Part D funding. Support for funding of Department of Homeland Security drug interdiction efforts. Issues related to pricing of prescription drugs. Monitoring H.R.3, Lower Drug Costs Now Act of 2019 and S.2543, Prescription Drug Pricing Reduction Act of 2019.
Client expense: — · Firm income: $20,000
Matched citations: H.R.3
Prescription Drug Pricing Reduction Act of 2019
2019 · third_quarter · Client: LILLY USA, LLC
Opposition to prescription drug importation and cuts to Medicare Part D funding. Support for funding of Department of Homeland Security drug interdiction efforts. Issues related to pricing of prescription drugs. Monitoring H.R.3, Lower Drug Costs Now Act of 2019 and S.2543, Prescription Drug Pricing Reduction Act of 2019.
Client expense: — · Firm income: $20,000
Matched citations: S.2543
Issues related to pricing of prescription drugs. Opposition to prescription drug importation and cuts to Medicare Part D funding; H.R.1892, Bipartisan Budget Act of 2018 (P.L.115-123). Support for funding of Department of Homeland Security drug interdiction efforts.
Client expense: — · Firm income: $20,000
Matched citations: H.R.1892
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
2017 · fourth_quarter · Client: LILLY USA, LLC
Monitored issues related to taxation of offshore revenue and corporate tax reform; H.R.1, Tax Cuts and Jobs Act (P.L.115-97).
Client expense: — · Firm income: $20,000
Matched citations: H.R.1
American Health Care Act of 2017
2017 · third_quarter · Client: LILLY USA, LLC
Issues related to Medicare Part D reform proposals in budget and health care reform proposals. H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: H.R.1628
American Health Care Act of 2017
2017 · second_quarter · Client: LILLY USA, LLC
Issues related to Medicare Part D reform proposals in budget and health care reform proposals. H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: H.R.1628
FDA Reauthorization Act of 2017
2017 · second_quarter · Client: LILLY USA, LLC
Issues related to pricing of prescription drugs. Opposition to prescription drug importation. Support for funding of Department of Homeland Security drug interdiction efforts. Issues related to reauthorization of the Prescription Drug User Fee Act. H.R.2430/S.934, FDA Reauthorization Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: H.R.2430
Issues related to pricing of prescription drugs. Opposition to prescription drug importation. Support for funding of Department of Homeland Security drug interdiction efforts. Issues related to reauthorization of the Prescription Drug User Fee Act. H.R.2430/S.934, FDA Reauthorization Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: S.934
Defend Trade Secrets Act of 2015
2016 · fourth_quarter · Client: LILLY USA, LLC
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act. Issues related to patent reform. Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Client expense: — · Firm income: $20,000
Matched citations: H.R.3326
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act. Issues related to patent reform. Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Client expense: — · Firm income: $20,000
Matched citations: H.R.6
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act. Issues related to patent reform. Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Client expense: — · Firm income: $20,000
Matched citations: S.1890
Defend Trade Secrets Act of 2015
2016 · third_quarter · Client: LILLY USA, LLC
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act. Issues related to patent reform. Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Client expense: — · Firm income: $20,000
Matched citations: H.R.3326
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act. Issues related to patent reform. Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Client expense: — · Firm income: $20,000
Matched citations: H.R.6
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act. Issues related to patent reform. Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Client expense: — · Firm income: $20,000
Matched citations: S.1890
Defend Trade Secrets Act of 2015
2016 · second_quarter · Client: LILLY USA, LLC
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act. Issues related to patent reform. Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Client expense: — · Firm income: $20,000
Matched citations: H.R.3326
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act. Issues related to patent reform. Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Client expense: — · Firm income: $20,000
Matched citations: H.R.6
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act. Issues related to patent reform. Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Client expense: — · Firm income: $20,000
Matched citations: S.1890
Defend Trade Secrets Act of 2015
2016 · first_quarter · Client: LILLY USA, LLC
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act. Issues related to patent reform. Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Client expense: — · Firm income: $20,000
Matched citations: H.R.3326
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act. Issues related to patent reform. Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Client expense: — · Firm income: $20,000
Matched citations: H.R.6
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act. Issues related to patent reform. Supporting The Defend Trade Secrets Act of 2015 (S.1890, H.R.3326).
Client expense: — · Firm income: $20,000
Matched citations: S.1890
Issues related to patent/IP protections for biotech and pharmaceutical drugs. Support for inclusion of Dormant Therapies Act in H.R.6, 21st Century Cures Act. Issues related to patent reform.
Client expense: — · Firm income: $20,000
Matched citations: H.R.6
Source: Senate LDA